In the news: GSK found guilty, regulators delay iPhone 6 launch and China business law checklist produced

This week GlaxoSmithKline was handed the largest ever corporate fine in China, Apple waited on regulatory approval to sell its latest iPhone and a checklist for foreign companies doing business in China was discussed

5 minute readSeptember 26, 2014 at 04:26 AM

clpstaff

& clp articles

GSK pays US$489 million for bribery

A Chinese court found drug maker GlaxoSmithKline's local subsidiary guilty of bribery and fined the company US$489 million (Rmb3 billion), concluding this part of

A Subscription is Required to Access this Content

Subscribe to China Law & Practice today for:

✓ A database of 3000+ essential documents, including key PRC laws translated into English
✓ Newsletters with business-critical and sector-specific updates
✓ Premium mobile access with timely analysis on China's fast-changing market

Already a Subscriber? Log In. Sign In Now

Questions? Contact us at [email protected] | 1-855-808-4530 (Americas) | 44(0) 800 098 386009 (UK & Europe)